PSA-targeted Alpha-, Beta- and Positron Emitting Immuno-Theranostics in Murine Prostate Cancer Models and Non-Human Primates
D. Veach, C. M. Storey, K. Lueckerath, K. Braun, C. van Bodman, U. Lamminmaeki, T. Kalidindi, S.-E. Strand, J. Strand, M. Altai, R. Damoiseaux, P. Zanzonico, N. Benabdallah, D. Pankov, H. I. Scher, , D. Ulmert
This paper evaluates the theranostic potential of hu5A10 in prostate cancer models, showing it reduces tumor burden and prolongs survival.
bioRxiv · Sep 11, 2020 · PreprintCancer Biology